Want to join the conversation?
$BIIB said that opicinumab also did not meet the secondary efficacy endpoint in Synergy study, which evaluated the slowing of disability progression, safety and pharmacokinetics. Synergy results will be presented at future medical meetings.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.